However, the breast cancer cohort examined in the current study is distinct from previously published cohorts, as it consisted entirely of primary ERα+, sporadic cases, which contained both node positive and negative cases, the majority of women were postmenopausal and the patients all received adjuvant tamoxifen treatment following surgery and radiation. This evidence concerns the gene ESR1 and breast carcinoma.